Cargando…

Association of SLC22A1, SLC22A2, SLC47A1, and SLC47A2 Polymorphisms with Metformin Efficacy in Type 2 Diabetic Patients

Response to metformin, first-line therapy for type 2 diabetes mellitus (T2DM), exists interindividual variation. Considering that transporters belonging to the solute carrier (SLC) superfamily are determinants of metformin pharmacokinetics, we evaluated the effects of promoter variants in organic ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Peixian, Cao, Yumin, Chen, Shenren, Liu, Zhike, Chen, Shiyi, Guo, Yali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599747/ https://www.ncbi.nlm.nih.gov/pubmed/36289808 http://dx.doi.org/10.3390/biomedicines10102546

Ejemplares similares

Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
por: Gorecki, Matthias, et al.
Publicado: (2020)

The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients
por: Xiao, Di, et al.
Publicado: (2016)

Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels
por: AL-Eitan, Laith N., et al.
Publicado: (2019)

The influence of metformin transporter gene SLC22A1 and SLC47A1 variants on steady-state pharmacokinetics and glycemic response
por: Ningrum, Vitarani Dwi Ananda, et al.
Publicado: (2022)

Genomic editing of metformin efficacy-associated genetic variants in SLC47A1 does not alter SLC47A1 expression
por: Kalamajski, Sebastian, et al.
Publicado: (2021)

Pharmacogenetic variation of SLC47A1 gene and metformin response in type2 diabetes patients
por: Mousavi, Saeedeh, et al.
Publicado: (2017)

Interaction of Natural Dietary and Herbal Anionic Compounds and Flavonoids with Human Organic Anion Transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11)
por: Wang, Li, et al.
Publicado: (2013)

Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?
por: Brecht, Karin, et al.
Publicado: (2020)

The lipid flippase SLC47A1 blocks metabolic vulnerability to ferroptosis
por: Lin, Zhi, et al.
Publicado: (2022)

The SLC25A47 locus controls gluconeogenesis and energy expenditure
por: Yook, Jin-Seon, et al.
Publicado: (2023)

Impact of ATM and SLC22A1 Polymorphisms on Therapeutic Response to Metformin in Iranian Diabetic Patients
por: Shokri, Fazlollah, et al.
Publicado: (2016)

Evidence for the association of the SLC22A4 and SLC22A5 genes with Type 1 Diabetes: a case control study
por: Santiago, Jose Luis, et al.
Publicado: (2006)

Amplicon targeted resequencing for SLC2A9 and SLC22A12 identified novel mutations in hypouricemia subjects
por: Zhou, Zhaowei, et al.
Publicado: (2019)

Evaluation of the Influence of Genetic Variants of SLC2A9 (GLUT9) and SLC22A12 (URAT1) on the Development of Hyperuricemia and Gout
por: Pavelcova, Katerina, et al.
Publicado: (2020)

Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance
por: Heise, Michael, et al.
Publicado: (2012)

SLC-2000: a luminosity upgrade for the SLC
por: Breidenbach, M, et al.
Publicado: (1996)

Interaction of rs316019 variants of SLC22A2 with metformin and other drugs- an in silico analysis
por: Sajib, Abu Ashfaqur, et al.
Publicado: (2018)

Polymorphisms in GCKR, SLC17A1 and SLC22A12 were associated with phenotype gout in Han Chinese males: a case–control study
por: Zhou, Zhao-Wei, et al.
Publicado: (2015)

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment
por: Jaruskova, Monika, et al.
Publicado: (2017)

Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter
por: Console, Lara, et al.
Publicado: (2018)

Erratum to: Polymorphisms in GCKR, SLC17A1 and SLC22A12 were associated with phenotype gout in Han Chinese males: a case–control study
por: Zhou, Zhao-Wei, et al.
Publicado: (2015)

SLC37A1 and SLC37A2 Are Phosphate-Linked, Glucose-6-Phosphate Antiporters
por: Pan, Chi-Jiunn, et al.
Publicado: (2011)

ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population
por: Liu, Jia, et al.
Publicado: (2020)

Impact of Genetic Polymorphisms of SLC2A2, SLC2A5, and KHK on Metabolic Phenotypes in Hypertensive Individuals
por: Le, MyPhuong T., et al.
Publicado: (2013)

Association study of polymorphisms in the neutral amino acid transporter genes SLC1A4, SLC1A5 and the glycine transporter genes SLC6A5, SLC6A9 with schizophrenia
por: Deng, Xiangdong, et al.
Publicado: (2008)

SLC2A12 of SLC2 Gene Family in Bird Provides Functional Compensation for the Loss of SLC2A4 Gene in Other Vertebrates
por: Xiong, Ying, et al.
Publicado: (2020)

Pathogenic Variants of SLC22A12 (URAT1) and SLC2A9 (GLUT9) in Spanish Patients with Renal Hypouricemia: Founder Effect of SLC2A9 Variant c.374C>T; p.(T125M)
por: Perdomo-Ramirez, Ana, et al.
Publicado: (2023)

Association Study of the SLC1A2 (rs4354668), SLC6A9 (rs2486001), and SLC6A5 (rs2000959) Polymorphisms in Major Depressive Disorder
por: Rodek, Patryk, et al.
Publicado: (2022)

Association of polymorphisms of calcium reabsorption genes SLC12A1, KCNJ1 and SLC8A1 with colorectal adenoma
por: Lai, Xiaolian, et al.
Publicado: (2023)

Interactions of 172 plant extracts with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8): a study on herb-drug interactions
por: Lu, Hang, et al.
Publicado: (2017)

Functional Characterization of Rare Variants in OAT1/SLC22A6 and OAT3/SLC22A8 Urate Transporters Identified in a Gout and Hyperuricemia Cohort
por: Vávra, Jiří, et al.
Publicado: (2022)

Polymorphisms of ABCG2 and SLC22A12 Genes Associated with Gout Risk in Vietnamese Population
por: Thuy Duong, Nguyen, et al.
Publicado: (2019)

Active Hydrophilic Components of the Medicinal Herb Salvia miltiorrhiza (Danshen) Potently Inhibit Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8)
por: Wang, Li, et al.
Publicado: (2012)

Polymorphisms of SLC22A9 (hOAT7) in Korean Females with Osteoporosis
por: Ahn, Seong Kyu, et al.
Publicado: (2015)

Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition
por: Lozano, Elisa, et al.
Publicado: (2018)

Interactions of antiretroviral drugs with the SLC22A1 (OCT1) drug transporter
por: Moss, Darren M., et al.
Publicado: (2015)

Beam-beam simulations with non-gaussian distributions for SLC and SLC-2000
por: Bane, Karl Leopold Freitag, et al.
Publicado: (1998)

The human glucose and lipid homeostasis–associated genetic polymorphisms do not regulate SLC25A47 gene expression in the liver
por: Ren, Huan, et al.
Publicado: (2023)

The correlation and role analysis of SLC30A1 and SLC30A10 in cervical carcinoma
por: Zhang, Jing, et al.
Publicado: (2022)

Genetic variants in SLC22A3 contribute to the susceptibility to colorectal cancer
por: Ren, Anjing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tn0ucu6lms2u2ibun23vk28h84